{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:13:41Z","timestamp":1773695621402,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"DOI":"10.1007\/s00381-026-07211-1","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:14:09Z","timestamp":1773692049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraventricular treatment experience in children with central nervous system infections"],"prefix":"10.1007","volume":"42","author":[{"given":"Tugce Tural","family":"Kara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"Tekeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"7211_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/archdischild-2022-324559","volume":"108","author":"E Konrad","year":"2023","unstructured":"Konrad E, Robinson JL, Hawkes MT (2023) Cerebrospinal fluid shunt infections in children. Arch Dis Child 108:693\u2013697","journal-title":"Arch Dis Child"},{"key":"7211_CR2","first-page":"4557","volume":"9","author":"J Chen","year":"2016","unstructured":"Chen J, Wang Y, Yang L, Zhang C, Chen W, He J, Chen L, Zhu J, Li P (2016) Infections of ventriculoperitoneal shunt and a simple effective treatment. Int J Clin Exp Med 9:4557\u20134562","journal-title":"Int J Clin Exp Med"},{"key":"7211_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/INF.0000000000003513","volume":"41","author":"A McAlpine","year":"2022","unstructured":"McAlpine A, Robinson JL, Barton M, Balamohan A, Davies HD, Skar G, Lefebvre MA, Almadani A, Freire D, Le Saux N, Bowes J, Srigley JA, Passarelli P, Bradley J, Khan S, Purewal R, Viel-Th\u00e9riault I, Ranger A, Hawkes MT, Paediatric Investigators Collaborative Network on Infections in Canada (2022) Cerebrospinal fluid shunt infections: a multicenter pediatric study. Pediatr Infect Dis J 41:449\u2013454","journal-title":"Pediatr Infect Dis J"},{"key":"7211_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10143-025-03234-5","volume":"48","author":"CU Onyia","year":"2025","unstructured":"Onyia CU, Ogunbameru IO, Dada OA, Owagbemi OF, Ige-Orhionkpaibima FS, Olarewaju OA, Omon H, Ajekwu T, Anele C, Balogun S, Komolafe EO (2025) Ventriculoperitoneal shunt infection: insights from a single-center comparative analysis. Neurosurg Rev 48:69","journal-title":"Neurosurg Rev"},{"key":"7211_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jgar.2022.02.009","volume":"29","author":"SN Mostafavi","year":"2022","unstructured":"Mostafavi SN, Khedmati M, Kelishadi R (2022) Microbiology and antimicrobial sensitivity of ventriculo-peritoneal shunt infections in a referral paediatric neurosurgery ward during a period of 7 years. J Glob Antimicrob Resist 29:63\u201367","journal-title":"J Glob Antimicrob Resist"},{"key":"7211_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/00006454-200207000-00006","volume":"21","author":"RT Schreffler","year":"2002","unstructured":"Schreffler RT, Schreffler AJ, Wittler RR (2002) Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 21:632\u2013636","journal-title":"Pediatr Infect Dis J"},{"key":"7211_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40272-013-0017-5","volume":"15","author":"AK Sullins","year":"2013","unstructured":"Sullins AK, Abdel-Rahman SM (2013) Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatr Drugs 15:93\u2013117","journal-title":"Paediatr Drugs"},{"key":"7211_CR8","volume":"7","author":"I Alnaami","year":"2022","unstructured":"Alnaami I, Alahmari Z (2022) Intrathecal\/Intraventricular colistin for antibiotic-resistant bacterial CNS infections in pediatric population: a systematic review. Trop Med Infect Dis 7:41","journal-title":"Trop Med Infect Dis"},{"key":"7211_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/cid\/ciw861","volume":"64","author":"AR Tunkel","year":"2017","unstructured":"Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TP, Garton HJL, Zunt JR (2017) 2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis 64:34\u201365","journal-title":"Clin Infect Dis"},{"key":"7211_CR10","unstructured":"Centers for Disease Control and Prevention (CDC) (2023) CDC\/NHSN surveillance definitions for specific types of infections. In: National Healthcare Safety Network (NHSN) Patient safety component manual, Chapter 17. Centers for Disease Control and Prevention, Atlanta. Available at: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf"},{"key":"7211_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1055\/a-1108-1699","volume":"232","author":"TT Kara","year":"2020","unstructured":"Kara TT, Kocaoglu M (2020) A ventriculoperitoneal shunt infection successfully treated with intraventricular coadministration of tigecycline and colistin. Klin Padiatr 232:70\u201372","journal-title":"Klin Padiatr"},{"key":"7211_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijantimicag.2013.02.006","volume":"41","author":"I Karaiskos","year":"2013","unstructured":"Karaiskos I, Galani L, Baziaka F, Giamarellou H (2013) Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents 41:499\u2013508","journal-title":"Int J Antimicrob Agents"},{"key":"7211_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12028-018-0647-0","volume":"30","author":"JJ Lewin 3rd","year":"2019","unstructured":"Lewin JJ 3rd, Cook AM, Gonzales C, Merola D, Neyens R, Peppard WJ, Brophy GM, Kurczewski L, Giarratano M, Makii J, Rowe AS, Tesoro EP, Zaniewski A, Clark S, Ziai WC (2019) Current practices of intraventricular antibiotic therapy in the treatment of meningitis and ventriculitis: results from a multicenter retrospective cohort study. Neurocrit Care 30:609\u2013616","journal-title":"Neurocrit Care"},{"key":"7211_CR14","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1128\/AAC.01461-12","volume":"57","author":"M Ziaka","year":"2013","unstructured":"Ziaka M, Markantonis SL, Fousteri M, Zygoulis P, Panidis D, Karvouniaris M, Makris D, Zakynthinos E (2013) Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 57:1938\u20131940","journal-title":"Antimicrob Agents Chemother"},{"key":"7211_CR15","first-page":"3","volume":"24","author":"O Bargiacchi","year":"2016","unstructured":"Bargiacchi O, De Rosa FG (2016) Intrathecal or intraventricular colistin: a review. Infez Med 24:3\u201311","journal-title":"Infez Med"},{"key":"7211_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ijantimicag.2017.12.002","volume":"51","author":"S Chusri","year":"2018","unstructured":"Chusri S, Sakarunchai I, Kositpantawong N, Panthuwong S, Santimaleeworagun W, Pattharachayakul S, Singkhamanan K, Doi Y (2018) Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii. Int J Antimicrob Agents 51:646\u2013650","journal-title":"Int J Antimicrob Agents"},{"key":"7211_CR17","volume":"7","author":"L Zhong","year":"2020","unstructured":"Zhong L, Shi XZ, Su L, Liu ZF (2020) Sequential intraventricular injection of tigecycline and polymyxin B in the treatment of intracranial Acinetobacter baumannii infection after trauma: a case report and review of the literature. Mil Med Res 7:23","journal-title":"Mil Med Res"},{"key":"7211_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.wneu.2019.07.045","volume":"130","author":"A \u015eahin","year":"2019","unstructured":"\u015eahin A, Dalgic N (2019) Intraventricular plus intravenous tigecycline for the treatment of daptomycin nonsusceptible vancomycin-resistant enterococci in an infant with ventriculoperitoneal shunt infection. World Neurosurg 130:470\u2013473","journal-title":"World Neurosurg"},{"key":"7211_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jcrc.2018.07.025","volume":"47","author":"V Tsolaki","year":"2018","unstructured":"Tsolaki V, Karvouniaris M, Manoulakas E, Kotlia P, Karadontas V, Fotakopoulos G, Zakynthinos E, Makris D (2018) Intraventricular CNS treatment with Colistin-Tigecycline combination: a case series. J Crit Care 47:338\u2013341","journal-title":"J Crit Care"},{"key":"7211_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WCO.0b013e32832c1396","volume":"22","author":"WC Ziai","year":"2009","unstructured":"Ziai WC, Lewin JJ 3rd (2009) Improving the role of intraventricular antimicrobial agents in the management of meningitis. Curr Opin Neurol 22:277\u2013282","journal-title":"Curr Opin Neurol"},{"key":"7211_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1056148","volume":"13","author":"SP Liu","year":"2022","unstructured":"Liu SP, Xiao J, Liu YL, Wu YE, Qi H, Wang ZZ, Shen AD, Liu G, Zhao W (2022) Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections. Front Pharmacol 13:1056148","journal-title":"Front Pharmacol"},{"key":"7211_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/IDR.S326456","volume":"15","author":"M Karvouniaris","year":"2022","unstructured":"Karvouniaris M, Brotis A, Tsiakos K, Palli E, Koulenti D (2022) Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis. Infect Drug Resist 15:697\u2013721","journal-title":"Infect Drug Resist"},{"key":"7211_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/1120009X.2021.1920249","volume":"33","author":"M Deniz","year":"2021","unstructured":"Deniz M, Tap\u0131s\u0131z A, B\u00f6rcek A\u00d6, Tezer H (2021) Intraventricular treatment of paediatric meningitis due to extensively drug-resistant Gram-negative bacteria: two case reports and review of the literature. J Chemother 33:509\u2013516","journal-title":"J Chemother"},{"key":"7211_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/INF.0000000000003439","volume":"41","author":"TA Almangour","year":"2022","unstructured":"Almangour TA, Alsubaie S, Ghonem L, Almohaini HA, Mohammed Bakheet H, Altweijri I (2022) Ceftazidime-avibactam for the treatment of multidrug-resistant Pseudomonas aeruginosa central nervous system infection in pediatric patient: a case report. Pediatr Infect Dis J 41:436\u2013438","journal-title":"Pediatr Infect Dis J"},{"key":"7211_CR25","first-page":"127","volume":"19","author":"H Ongun","year":"2024","unstructured":"Ongun H, Kihtir Z, Ozkan Zarif N, Koyuncu \u00d6zyurt \u00d6, Kara TT, \u00c7elik K, Aray\u0131c\u0131 S (2024) Challenges in diagnosis and treatment of neonatal ventriculitis: a case report and systematic review of difficult-to-treat central nervous system infection resistant to conventional therapy. J Pediatr 19:127\u2013139","journal-title":"J Pediatr"},{"key":"7211_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107334","volume":"64","author":"C Xu","year":"2024","unstructured":"Xu C, Zeng F, Xu Q, Yang Y, Zhang Y, Shi C (2024) Effectiveness of combination therapy with intrathecal or intraventricular administration of polymyxin B for hospital-acquired central nervous system infections caused by carbapenem-resistant Acinetobacter baumannii: a retrospective study. Int J Antimicrob Agents 64:107334","journal-title":"Int J Antimicrob Agents"},{"key":"7211_CR27","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/jac\/dkae193","volume":"79","author":"P Wang","year":"2024","unstructured":"Wang P, Liu S, He X, Miao W, Sun T, Yang J (2024) Therapeutic drug monitoring of polymyxin B cerebrospinal fluid concentrations in patients with carbapenem-resistant Gram-negative bacteria-induced central nervous system infection. J Antimicrob Chemother 79:1969\u20131973","journal-title":"J Antimicrob Chemother"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-026-07211-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:14:10Z","timestamp":1773692050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-026-07211-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7211"],"URL":"https:\/\/doi.org\/10.1007\/s00381-026-07211-1","relation":{},"ISSN":["1433-0350"],"issn-type":[{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}